权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cell Cycle Regulators in Pancreatic Development and Disease

胰腺发育和疾病中的细胞周期调节因子

基本信息

批准号：
10919443
负责人：
Sushil Rane
金额：
$ 67.91万
依托单位：
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10919443
关键词：
Acinar Cell Age Area Beta Cell Binding Bone Marrow CCND2 gene CDK2 gene CDK4 gene CDKN2A gene Cell Compartmentation Cell Cycle Cell Line Cell Lineage Cell Proliferation Cell physiology Cells Cellular biology Chemicals Clinical Cyclin D1 Deterioration Development Diabetes Mellitus Diagnostic Disease Ductal Epithelium E2F transcription factors Embryo Endocrine Epithelium Exhibits Generations Genetic Transcription Goals Growth Hyperplasia Impairment Injury Insulin Investigation Islets of Langerhans Knockout Mice Location Maintenance Mesenchymal Mesenchyme Metabolic stress Mus Natural regeneration Obesity Organ Pancreas Pancreatic Diseases Pancreatic duct Pathogenesis Pathologic Pathway interactions Phosphotransferases Physiological Play Pluripotent Stem Cells Primary Cell Cultures Process Proliferating Property Regenerative capacity Regenerative response Regulation Reporting Research Retinoblastoma Protein Role Source Splenocyte TP53 gene Therapeutic Toxin Translating autoimmune pathogenesis cell growth cell regeneration clinical application cyclin-dependent kinase inhibitor 1B diabetes management diabetes mellitus therapy embryonic stem cell established cell line functional disability inhibitor islet islet stem cells mortality mouse model novel pancreas development postnatal precursor cell progenitor proliferation potential promoter recruit response stem cells transdifferentiation treatment strategy

项目摘要

Insulin-producing pancreatic islet beta cells are destroyed, severely depleted or functionally impaired in diabetes. Therefore, replacing functional beta cell mass would advance clinical diabetes management. We have previously demonstrated the importance of Cdk4 in regulating beta cell mass. Cdk4-deficient mice display beta cell hypoplasia and develop diabetes, whereas beta cell hyperplasia is observed in mice expressing an active Cdk4R24C kinase. While beta cell replication appears to be the primary mechanism responsible for beta cell mass increase, considerable evidence also supports a contribution from the pancreatic ductal epithelium in generation of new beta cells. We conclude that Cdk4 not only promotes beta cell replication, but also facilitates the activation of beta cell progenitors in the ductal epithelium. In addition, we show that Cdk4 controls beta cell mass by recruiting quiescent cells to enter the cell cycle. We show that Cdk4 and its downstream transcription factor E2F1 regulate pancreas development prior to and during the secondary transition. Deficiency of Cdk4 results in reduced embryonic pancreas size due to impaired mesenchyme development and limitation of the number of Pdx1+ pancreatic progenitor cells. Interestingly, expression of activated Cdk4R24C kinase leads to increased Nkx2.2+ and Nkx6.1+ cells and a rise in the number and proliferation of Ngn3+ endocrine precursor cells resulting in expansion of the cell lineage. Further, we show that E2F1 binds and activates the Ngn3 promoter thereby modulating Ngn3 expression levels in the embryonic pancreas in a Cdk4-dependent manner. These results identify Cdk4 as an important regulator of early pancreas development by virtue of its ability to modulate the proliferation potential of pancreatic progenitors and endocrine precursors. We have begun a systematic analyses of other cell cycle regulators in pancreas development and function. We have recently uncovered an important role for CDK2 in beta cell function and post-natal beta cell proliferation. Cdk2 loss results in loss of beta cell function. Further, age associated reduction in beta cell mass is seen upon Cdk2 deficiency. Also, we observe that metabolic stress further accentuates the defecst due to loss of Cdk2 by further deterioration of beta cell mass and function. We are presently investigating the mechanisms that underlie these findings. We are also studying the interaction of endocrine pancreas and other organs.

产生胰岛素的胰岛β细胞在糖尿病中被破坏、严重耗尽或功能受损。因此，替换功能性β细胞群将推进临床糖尿病管理。我们以前已经证明了Cdk4在调节β细胞群中的重要性。Cdk4缺陷小鼠显示β细胞发育不全并发展为糖尿病，而在表达活性Cdk4R24C激酶的小鼠中观察到β细胞增生。虽然β细胞复制似乎是导致β细胞质量增加的主要机制，但大量证据也支持胰腺导管上皮在产生新β细胞中的贡献。我们得出结论，Cdk4不仅促进β细胞复制，而且还促进导管上皮中β细胞祖细胞的激活。此外，我们发现Cdk4通过招募静止细胞进入细胞周期来控制β细胞群。我们发现，Cdk4和它的下游转录因子E2F1调节胰腺发育之前和期间的次级转换。由于间充质发育受损和Pdx 1+胰腺祖细胞数量的限制，Cdk4的缺乏导致胚胎胰腺大小减小。有趣的是，活化的Cdk4R24C激酶的表达导致Nkx2.2+和Nkx6.1+细胞的增加以及Ngn 3+内分泌前体细胞的数量和增殖的增加，从而导致细胞谱系的扩增。此外，我们表明，E2F1结合并激活Ngn3启动子，从而调节Ngn3在胚胎胰腺中的表达水平在Cdk4依赖的方式。这些结果确定Cdk4作为早期胰腺发育的重要调节因子，其能够调节胰腺祖细胞和内分泌前体细胞的增殖潜力。我们已经开始对胰腺发育和功能中的其他细胞周期调节因子进行系统分析。我们最近发现了CDK2在β细胞功能和出生后β细胞增殖中的重要作用。Cdk2的缺失导致β细胞功能的丧失。此外，在Cdk2缺乏时观察到与年龄相关的β细胞群减少。此外，我们观察到，代谢应激进一步加重由于Cdk2的损失，β细胞质量和功能的进一步恶化的缺陷。我们目前正在研究这些发现背后的机制。我们还在研究胰腺内分泌与其他器官的相互作用。